Maurício de Maio1. 1. Avenida Ibirapuera, 2907 cj 1202 CEP: 04029-200, Moema, São Paulo, Brazil. mauriciodemaio@uol.com.br
Abstract
BACKGROUND: The therapeutic uses of botulinum toxin have been expanding due to deeper knowledge of its molecular behaviour and different mechanisms of action. OBJECTIVE: To present suggested doses of Botox and Dysport for controlling the muscle hyperkinetic activity in facial palsy in the perioral area and to review other uses. METHODS: An extensive updated literature review on the success and limits of the botulinum neurotoxin (BoNT) therapeutic treatments. RESULTS/ CONCLUSION: BoNT can be considered to be the preferred single method for many disorders; it has substituted for some conventional surgical methods and it can be associated with other therapies to increase overall treatment performance. Depending on the disorder, the lack of permanent effect causes no major inconvenience.
BACKGROUND: The therapeutic uses of botulinum toxin have been expanding due to deeper knowledge of its molecular behaviour and different mechanisms of action. OBJECTIVE: To present suggested doses of Botox and Dysport for controlling the muscle hyperkinetic activity in facial palsy in the perioral area and to review other uses. METHODS: An extensive updated literature review on the success and limits of the botulinum neurotoxin (BoNT) therapeutic treatments. RESULTS/ CONCLUSION:BoNT can be considered to be the preferred single method for many disorders; it has substituted for some conventional surgical methods and it can be associated with other therapies to increase overall treatment performance. Depending on the disorder, the lack of permanent effect causes no major inconvenience.
Authors: M Brown; G Nicholson; M C Ardila; A Satorius; R S Broide; K Clarke; T Hunt; J Francis Journal: J Neural Transm (Vienna) Date: 2012-07-29 Impact factor: 3.575
Authors: Ewa Bomba-Warczak; Jason D Vevea; Joel M Brittain; Annette Figueroa-Bernier; William H Tepp; Eric A Johnson; Felix L Yeh; Edwin R Chapman Journal: Cell Rep Date: 2016-08-04 Impact factor: 9.423
Authors: James C Burnett; Bing Li; Ramdas Pai; Steven C Cardinale; Michelle M Butler; Norton P Peet; Donald Moir; Sina Bavari; Terry Bowlin Journal: Open Access Bioinformatics Date: 2010-04-01
Authors: Gordon Ruthel; James C Burnett; Jonathan E Nuss; Laura M Wanner; Lyal E Tressler; Edna Torres-Melendez; Sarah J Sandwick; Cary J Retterer; Sina Bavari Journal: Toxins (Basel) Date: 2011-03-15 Impact factor: 4.546
Authors: Rosalind Brown; Kosala N Dissanayake; Paul A Skehel; Richard R Ribchester Journal: Ann Clin Transl Neurol Date: 2014-10-10 Impact factor: 4.511